You searched for "specialty"
An educational intervention to improve adherence to high-dosage patching regimen for amblyopia
This is a randomised trial of patients recruited between the periods of March 2006 and March 2008 from ophthalmology clinics in the Leicestershire area. A total of 62 children with newly diagnosed amblyopia were allocated randomly into two treatment arms...Altomed is thrilled to announce the sponsorship of its 2nd Guide Dog puppy Geordie!
Named in tribute to Altomed’s Northeast roots, Geordie is a striking black German Shepherd, confident, clever, and full of character. His unique breed makes him extra special within the Guide Dogs community. Geordie follows in the pawprints of Altomed’s first...Charity partners celebrate 10 years in Zambia
Vision Aid Overseas and Specsavers are celebrating 10 years of working together.Orbis celebrates International Day of Friendship
International eyecare charity Orbis recognises the importance of strong bonds on International Day of Friendship 2023.High-stakes scenarios in retinal vein occlusion: A survey of medico-legal implications
Central retinal vein occlusion (CRVO) is the second most common retinal vascular disease after diabetic retinopathy, and its clinical complexity often intersects with medico-legal scrutiny [1]. Missteps in timely diagnosis, inadequate follow-up or poor documentation can lead to patient harm...You want to do paediatric ophthalmology? Seriously?
Completion of Core Training is approaching fast and you begin to wonder three things. One, where do you want to live? Two, is anyone going to be retiring there soon? Three, what subspecialty do you want to do? In an...Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease
Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...In conversation with Robert Henderson
Revolutionary eye treatments offer hope for children facing blindness from CLN2 batten disease. Robert Henderson discusses this, and his use of Heidelberg Engineering’s Spectralis device to better combat it. Pioneering research from Great Ormond Street Hospital (GOSH) and the University...
